Company Profile

NeuroPrex Inc
Profile last edited on: 7/2/19      CAGE: 7GA60      UEI: M5Y6E4SGA8L3

Business Identifier: Treatment technologies for depression and other neurological disorders
Year Founded
2012
First Award
2018
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2040 Martin Avenue
Santa Clara, CA 95050
   (408) 688-1707
   service@neuroprexinc.com
   www.neuroprexinc.com
Location: Single
Congr. District: 17
County: Santa Clara

Public Profile

NeuroPrex Inc develops treatment technologies for depression and other neurological disorders such as PTSD. The company's technology is a Repetitive Transcranial Magnetic Stimulation device which provides a strong healing effect with reduced side effects, creates new synaptic connections, increases oxygen uptake and metabolism rates, modulates cellular function and triggers anti-inflammatory effects.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 1 NSF $224,925
Project Title: A Novel, Protective Shield to Increase Safety and Efficacy of rTMS Depression Treatment

Key People / Management

  Hsiu (Janice) Huang -- CEO, Founder and Principle Investigator

  Hans Pan